CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 10, 2021 / 01:00PM GMT
Release Date Price: R$50.91 (-0.50%)
Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Hi, everyone. I'm A.J. Rice, the health care service analyst at Credit Suisse. We're very pleased to have up next presenting, CVS. We have Shawn Guertin, Chief Financial Officer; and Susie Lisa, Senior Vice President of Investor Relations. Thank you guys for participating once again in our conference.

Questions & Answers

Albert J. William Rice;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Shawn, you joined CVS earlier this year with a few months under your belt now. What have been your major learnings? So sort of open with a pretty high-level question, what have been some positive surprises? What have been the challenges that you're seeing?

Shawn Michael Guertin
CVS Health Corporation - Executive VP & CFO

Yes. No. Thanks, A.J., and good morning, everyone. Overall, I would say I haven't really been surprised by anything. I would say on the -- I would say on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot